Alliqua BioMedical is a regenerative technologies company which commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing, Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies, and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The Company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

Type
Public
HQ
Yardley, US
Founded
1997
Size (employees)
81 (est)
Alliqua was founded in 1997 and is headquartered in Yardley, US
Report incorrect company information

Key People/Management at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Brian Posner

Brian Posner

CFO
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs
Nino Pionati

Nino Pionati

Chief Strategy and Marketing Officer
Gregory Robb

Gregory Robb

VP Operations
Show more

Alliqua Office Locations

Alliqua has an office in Yardley
Yardley, US (HQ)
1010 Stony Hill Road, Suite 200
Show all (1)
Report incorrect company information

Alliqua Financials and Metrics

Alliqua Revenue

Embed Graph
Alliqua's revenue was reported to be $18.24 m in FY, 2016 which is a 21.3% increase from the previous period.
USD

Net income (Q2, 2017)

(4.2 m)

EBIT (Q2, 2017)

(3.8 m)

Market capitalization (18-Jul-2018)

11 m

Closing share price (18-Jul-2018)

2.2

Cash (30-Jun-2017)

2.3 m
Alliqua's current market capitalization is $11 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8 m4.8 m15 m18.2 m

Revenue growth, %

166%214%21%

Cost of goods sold

2.1 m3.3 m6 m6.7 m

Gross profit

(299.3 k)1.5 m9 m11.6 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

438 k

Cost of goods sold

586.7 k631.7 k836.7 k915.8 k1.2 m1.4 m1.7 m1.8 m1.6 m1.8 m1.7 m1.9 m

Gross profit

(148.7 k)

Gross profit Margin, %

(34%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.1 m16.8 m26.1 m5.6 m

Accounts Receivable

156.8 k968.6 k2.5 m2.8 m

Inventories

88.4 k477.8 k942 k2.7 m

Current Assets

12.8 m19.6 m32.7 m11.8 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

9.6 m23.8 m19.9 m10.9 m35.8 m30.7 m17 m12.6 m10.7 m2.4 m2.3 m

Accounts Receivable

164.1 k474.4 k715.6 k1.4 m2.3 m2.4 m2.5 m2.5 m2.7 m2.9 m3.6 m

Inventories

501.1 k940.7 k1.1 m1.6 m2.9 m3.5 m3.5 m3.1 m3.2 m2.6 m2.8 m

Current Assets

10.5 m25.3 m22 m14.8 m41.7 m37.5 m24.1 m23.5 m17.6 m8.3 m8.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(22 m)(25.4 m)(26 m)(28.2 m)

Depreciation and Amortization

674.2 k2.9 m4.2 m

Inventories

105.3 k477.8 k(257.3 k)(113 k)

Accounts Payable

174 k1.8 m571.6 k(26 k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(7 m)(9 m)(6 m)(5.1 m)(7.7 m)(7 m)(7.1 m)(7.7 m)5.2 m(8.6 m)(7 m)

Depreciation and Amortization

492.9 k

Inventories

18 k

Accounts Payable

179.7 k1.6 m1.1 m1.8 m2.4 m2.8 m2.4 m2.1 m2.6 m2.3 m
USDY, 2017

Financial Leverage

1.7 x
Show all financial metrics
Report incorrect company information

Alliqua Online and Social Media Presence

Embed Graph
Report incorrect company information

Alliqua Company Life and Culture

Report incorrect company information